Previous 10 | Next 10 |
AUSTIN, Texas, April 03, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) and BioBridge Global today announced their collaboration to participate in a U.S. Food and Drug Administration (FDA) investigational program for U.S. blood centers to begin collecting and distributing convalescen...
Introduction: XBiotech Inc. ( XBIT ) is a pre-market biopharmaceutical company. They are in the business of trying to develop and commercialize “True Human”™ monoclonal antibodies to treat various diseases including type 2 diabetes, infectious diseases, cardiovasc...
AUSTIN, Texas, Feb. 19, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) today announced the final results of its “modified Dutch auction” tender offer, which expired at 5:00 p.m., New York City time, on February 12, 2020. Based on the final ...
AUSTIN, Texas, Feb. 13, 2020 (GLOBE NEWSWIRE) -- This press release corrects a prior version published on February 13, 2020 and is updated to revise the preliminary proration factor. The corrected press release reads: XBiotech Announces Preliminary Results of Tender Offer XBiotec...
Gainers: CounterPath (NASDAQ: CPAH ) +32% . More news on: CounterPath Corporation, Genprex, Inc., Happiness Biotech Group Limited, Stocks on the move, , Read more ...
After XBiotech (NASDAQ: XBIT) announced that investors tendering shares as part of its buyback will be able to tender only 30.9 shares for every 100 desired, shares are down 23.4% as of 11:30 a.m. EST on Thursday. In December, XBiotech completed the sale of its only clinical-stage...
XBiotech (NASDAQ: XBIT ) -26% on preliminary results of tender offer . More news on: XBiotech Inc., Akorn, Inc., Catalyst Biosciences, Inc., Stocks on the move, , Read more ...
XBiotech (NASDAQ: XBIT ) slumps 30% premarket on average volume on the heels of preliminary results from its tender offer announced a month ago. More news on: XBiotech Inc., Healthcare stocks news, Stocks on the move, Read more ...
AUSTIN, Texas, Feb. 13, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) today announced the preliminary results of its “modified Dutch auction” tender offer, which expired at 5:00 p.m., New York City time, on February 12, 2020. Based on the pre...
On Tuesday, XBiotech Inc. ( XBIT ) rose 31% to $24.33 after the company announced that it intends to proceed with a partial tender offer of its shares in the $30 to $33 range for $420 million. It followed that up with another green day on Wednesday to close at $24.94, which is still a 20% di...
News, Short Squeeze, Breakout and More Instantly...
AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for advanced pancreatic cancer. Known as 1-BETTER, the study examined Natrunix (anti-interleukin-1alpha) anti...
2024-06-06 21:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-16 07:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...